Abstract
The development of a functional vasculature within a tumour is a requisite for its growth and progression. This fact has led to the design of therapies directed toward the tumour vasculature, aiming either to prevent the formation of new vessels (anti-angiogenic) or to damage existing vessels (vascular targeting). The development of agents with different mechanisms of action requires powerful preclinical models for the analysis and optimization of these therapies. This review concerns 'classical' assays of angiogenesis in vitro and in vivo, recent approaches to target identification (analysis of gene and protein expression), and the study of morphological and functional changes in the vasculature in vivo (imaging techniques). It mainly describes assays designed for anti-angiogenic compounds, indicating, where possible, their application to the study of vascular-targeting agents.
Original language | English |
---|---|
Pages (from-to) | 881-889 |
Number of pages | 9 |
Journal | European Journal of Cancer |
Volume | 40 |
Issue number | 6 |
DOIs | |
Publication status | Published - Apr 2004 |
Keywords
- Angiogenesis
- Angiogenesis inhibitors
- Endothelial cells
- Imaging
- Preclinical assays
- Tumour vasculature
- Vascular-targeting agents
ASJC Scopus subject areas
- Cancer Research
- Hematology
- Oncology